cyproterone acetate has been researched along with drospirenone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Noort, I; Rosendaal, FR; Rosing, J; van Vliet, HA; Winkel, TA | 1 |
| Tan, JK | 1 |
| Emons, G; Faber, M; Günthert, AR; Hellriegel, S; Knappe, G | 1 |
| Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA | 1 |
| Cabral, CA; Cardoso, LE; Sampaio, FJ; Zamboni, MJ | 1 |
| Gul, S; Kelekci, KH; Kelekci, S; Yengel, I; Yilmaz, B | 1 |
| Biringer, K; Biringerová, Z; Svecová, I; Visnovský, J | 1 |
| Bhattacharya, SM; Jha, A | 1 |
| Dokras, A | 1 |
| Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
| Atabekoğlu, CS; Ateş, C; Berker, B; Cetinkaya, SE; Kahraman, K; Ozmen, B; Sönmezer, M; Sükür, YE; Taşkın, S; Tolunay, HE | 1 |
| Beasley, R; Braithwaite, I; Shirtcliffe, P; Weatherall, M | 1 |
| Feng, GM; Huang, W; Song, Y; Wang, QS; Wang, QY; Xiao, L | 1 |
| Czilli, T; Knezevic, S; Peters, C; Tan, J | 1 |
| Li, J; Ren, J; Sun, W | 1 |
| Conard, J; Gompel, A; Horellou, MH; Hugon-Rodin, J; Plu-Bureau, G | 1 |
| Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E | 1 |
| Cai, G; Gu, M; Li, X; Mueck, AO; Ruan, X; Wang, L; Zhao, Y | 1 |
| Li, Y; Liu, C; Qiu, Y; Xu, M; Yang, X; Zhang, G | 1 |
2 review(s) available for cyproterone acetate and drospirenone
| Article | Year |
|---|---|
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome | 2017 |
6 trial(s) available for cyproterone acetate and drospirenone
| Article | Year |
|---|---|
Oral hormonal contraceptives affect the concentration and composition of urinary glycosaminoglycans in young women.
Topics: Adult; Androstenes; Chondroitin Sulfates; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dermatan Sulfate; Ethinyl Estradiol; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Norpregnenes | 2009 |
Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Severity of Illness Index; Spironolactone; Time Factors; Treatment Outcome; Young Adult | 2012 |
[Hormonal treatment effectivity in hyperandrogenic syndrome].
Topics: Adult; Androgen Antagonists; Androstenes; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Syndrome | 2010 |
Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Blood Glucose; Blood Pressure; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Female; Follow-Up Studies; Hirsutism; Humans; Insulin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2012 |
Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenes; Biomarkers; Body Mass Index; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Lipids; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Polycystic Ovary Syndrome; Treatment Outcome; Turkey; Waist-Hip Ratio | 2014 |
Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial.
Topics: Adolescent; Adult; Androstenes; Carbohydrate Metabolism; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Insulin Resistance; Life Style; Lipids; Metformin; Polycystic Ovary Syndrome; Prospective Studies | 2016 |
11 other study(ies) available for cyproterone acetate and drospirenone
| Article | Year |
|---|---|
Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Cyproterone Acetate; Humans; Male; Middle Aged; Predictive Value of Tests; Thrombophilia | 2004 |
Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Androgen Antagonists; Androstenes; Case-Control Studies; Chlormadinone Acetate; Clobetasol; Contraceptives, Oral; Cyproterone Acetate; Female; Glucocorticoids; Humans; Imiquimod; Incidence; Nandrolone; Premenopause; Progesterone; Retrospective Studies; Risk Factors; Treatment Outcome; Vulvar Lichen Sclerosus | 2008 |
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia | 2008 |
In search of the best combined oral contraceptive for treatment of polycystic ovary syndrome.
Topics: Androstenes; Cyproterone Acetate; Desogestrel; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 2012 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
Anti-androgen contraceptive pills and higher risk of venous thromboembolism.
Topics: Adolescent; Adult; Aged; Androgen Antagonists; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Female; Humans; Middle Aged; New Zealand; Risk Factors; Venous Thromboembolism; Young Adult | 2016 |
Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Androstenes; Anti-Bacterial Agents; Benzoyl Peroxide; Canada; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Doxycycline; Drug Combinations; Estrogens; Ethinyl Estradiol; Humans; Isotretinoin; Mineralocorticoid Receptor Antagonists; Minocycline; Practice Guidelines as Topic; Severity of Illness Index; Tetracycline | 2016 |
Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
Topics: Adolescent; Adult; Androstenes; Blood Coagulation Disorders, Inherited; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Factor V; Female; Humans; Incidence; Middle Aged; Paris; Premenopause; Progestins; Risk Factors; Venous Thromboembolism; Young Adult | 2018 |
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism | 2018 |
Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Topics: Androstenes; Animals; Breast Neoplasms; Cell Proliferation; Cyproterone Acetate; Dydrogesterone; Estradiol; Female; Heterografts; Humans; In Vitro Techniques; MCF-7 Cells; Megestrol; Membrane Proteins; Mice; Mice, Nude; Nandrolone; Norethindrone; Progesterone; Progestins; Prospective Studies; Receptors, Progesterone | 2019 |
Biotransformation of cyproterone acetate, drospirenone, and megestrol acetate in agricultural soils: Kinetics, microbial community dynamics, transformation products, and mechanisms.
Topics: Animals; Biotransformation; Cyproterone Acetate; Megestrol Acetate; Progesterone Congeners; Progestins; Soil | 2023 |